治疗结束时PET/CT完全缓解在结内外周T细胞淋巴瘤中具有高度预后价值:澳加合作研究
该回顾性研究纳入2011至2024年澳大利亚淋巴瘤登记处和玛格丽特公主癌症中心数据库的451例结内外周T细胞淋巴瘤患者,评估治疗结束时PET/CT缓解的预后意义。中位随访43.1个月,达到影像学完全缓解(CR)者36个月总生存(OS)显著高于未达CR者(73.5% vs 20.9%,p<0.001),且CR在所有亚型中均具预后价值。EOT PET的阳性预测值(PPV)为90%,阴性预测值(NPV)仅43.1%。
要点
- EOT PET/CT CR是结内PTCL各亚型OS的强预后因素。
- 达到CR者36个月OS为73.5%,未达CR者仅20.9%。
- EOT PET的PPV高达90%,但NPV较低(43.1%)。
核心结论
- 治疗结束时PET/CT完全缓解对结内PTCL各亚型的OS具有强预后价值,高PPV可预测死亡但NPV较低难以预测生存。
研究设计与样本
- 回顾性研究,纳入2011至2024年澳大利亚淋巴瘤及相关疾病登记处和玛格丽特公主癌症中心淋巴瘤数据库的451例结内PTCL患者。
主要发现
- 中位随访43.1个月(95%CI 38.8%-48.3%)。
- 达到EOT影像学CR者36个月PFS为43.1%(95%CI 34.3%-51.5%)。
- 达到CR者36个月OS为73.5%(95%CI 65.3%-80%),未达CR者为20.9%(95%CI 12.9%-30.2%),p<0.001。
- EOT影像学CR在所有结内PTCL亚型中均对OS具有预后意义(p<0.001)。
- 36个月时EOT PET的PPV为90%(95%CI 80.5%-96.2%),NPV为43.1%(95%CI 34.3%-51.5%)。
临床怎么用
- EOT PET/CT达到CR可提供较强的有利预后信息,但未达CR者预后仍差,即使达到CR者结局亦不理想。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
While end-of-treatment (EOT) imaging after front-line therapy is prognostic in nodal peripheral T-cell lymphoma (PTCL), its subtype-specific significance remains unclear. Retrospective review of patients with nodal PTCL included in the Australasian Lymphoma and Related Diseases Registry and the Princess Margaret Cancer Centre lymphoma database between 2011 and 2024. Progression-free survival (PFS), overall survival (OS), and positive and negative predictive values (PPV/NPV) of an EOT positron emission tomography/computed tomography response were evaluated. We identified 451 patients. Median follow-up was 43.1-months (95% confidence interval [CI] 38.8%-48.3%). Patients achieving an EOT imaging complete remission (CR) had a 36-month PFS of 43.1% (95% CI 34.3%-51.5%). The 36-month OS was significantly higher in patients achieving CR compared with those who did not achieve a CR (73.5% [95% CI 65.3%-80%] vs. 20.9% [95% CI 12.9%-30.2%]; p < 0.001). EOT imaging CR remained prognostic for OS in all nodal PTCL subtypes (p < 0.001). At 36-months, EOT PET demonstrated a PPV of 90% (95% CI 80.5%-96.2%) and a NPV of 43.1% (95% CI 34.3%-51.5%). EOT PET/CT CR is strongly prognostic of OS across nodal PTCL subtypes with a high PPV for predicting death but poor NPV for predicting survival. Outcomes remain poor for patients not achieving a CR, with suboptimal outcomes even in those achieving CR.
引用
- Abeyakoon C, Wellard C, Murad V, et al. End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study. Br J Haematol. 2026. PMID: 42469158. doi:10.1111/bjh.70689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。